Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Heat Biologics Appoints Two New Board Members

This article was originally published in Scrip

Executive Summary

Heat Biologics, Inc., a cancer immunotherapy company, has appointed Holbrook Kohrt and Kapil Dhingra to its scientific and clinical advisory board. Kohrt is currently assistant professor of medicine, division of oncology at the Stanford University of Medicine, CA, and is also a board certified medical oncologist and internist there. Most recently, Dhingra held various management positions at Roche Pharmaceuticals, including vice-president, head of oncology and disease leadership team and head of oncology clinical development. He was also involved in the expansion of Roche Oncology. Prior to this Dhingra was senior clinical research physician at Eli Lilly and is currently managing member and founder of the healthcare firm, KAPital Consulting.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts